financetom
Business
financetom
/
Business
/
BMW shares drop after profit forecast cut on tariffs, China weakness
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMW shares drop after profit forecast cut on tariffs, China weakness
Oct 8, 2025 1:53 AM

BERLIN (Reuters) -BMW shares fell as much as 7% on Wednesday after the luxury automaker cut its 2025 earnings forecast, citing delays in U.S. and German customs refunds and continued weakness in China as trade tensions cloud its prospects.

The German company said late Tuesday it now expected pretax earnings to decline slightly this year, against previous guidance for a flat outcome versus 2024.

"The tariff news is disappointing, especially given our expectation that BMW could be well-positioned on tariffs vs peers," said RBC analysts about the carmaker whose biggest plant is in the U.S. and is Germany's top auto exporter by value.

EARNINGS AND CASH FLOW GUIDANCE CUT

Citing delays to refunds from customs, BMW halved expectations for free cash flow from its automotive business to above 2.5 billion euros ($2.9 billion), and narrowed its profit margin forecast for that business to 5-6% from 5-7%.

The automaker, which exports a range of SUV models to Europe from its U.S. plant, still assumes that the European Union will retroactively implement a tariff reduction to zero from current import duties of 10% following an EU-U.S. framework trade deal.

However, it expects a high three-digit million figure in customs reimbursements from the U.S. and Germany only next year.

UBS and JP Morgan said the timing of the tariff refund was not a big issue, and the focus should be more on the China-related reasons for the guidance cut.

"More important than the impact of tariffs will be the firm's ability to stabilise the volume momentum and pricing power in China in FY26, which will ultimately ensure the longer term competitiveness of the group," JPMorgan analysts wrote.

BMW said on Tuesday that while sales had risen in Europe and the U.S. in January-September, sales in China were below expectations.

Shares in German rival Mercedes Benz, which also reported declining sales due to tariffs and weakness in China on Tuesday, were down 3.5%.

BMW will publish its full quarterly results on November 5.

($1 = 0.8610 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Aug 5, 2025
07:36 AM EDT, 08/05/2025 (MT Newswires) -- Arteris ( AIP ) shares were 64% high pre-bell Tuesday, a day after the company said that AMD (AMD) has licensed its FlexGen network-on-chip interconnect IP. STAAR Surgical ( STAA ) stock was up 44% after the company agreed to be acquired by Alcon (ALC) for about $1.5 billion. Castle Biosciences ( CSTL...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Beer maker Molson Coors forecasts downbeat annual profit on aluminum tariff impact
Beer maker Molson Coors forecasts downbeat annual profit on aluminum tariff impact
Aug 5, 2025
Aug 5 (Reuters) - Molson Coors ( TAP/A ) forecast a bigger drop in its annual profit on Tuesday, hit by tariff impacts on costs of aluminum it uses for its beverage cans amid macroeconomic uncertainty in the U.S. President Donald Trump's fluctuating trade tariff policies have pressured consumer spending in the U.S. and caused customers to pare back on...
ImmunityBio Q2 revenue up 60%, surpassing market estimates, on strong sales of ANKTIVA
ImmunityBio Q2 revenue up 60%, surpassing market estimates, on strong sales of ANKTIVA
Aug 5, 2025
Overview * ImmunityBio Q2 2025 revenue rises 60% to $26.4 mln, beating analyst expectations * Company's revenue growth driven by ANKTIVA sales in BCG-unresponsive NMIBC * ImmunityBio ( IBRX ) ends Q2 with $153.7 mln in cash, plus $80 mln equity financing Result Drivers * ANKTIVA SALES - 60% revenue increase in Q2 2025 driven by strong sales of ANKTIVA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved